This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board Meeting on 16 Oct 2026 to consider Q2 and H1 FY27 results
PAUSHAKLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.1 pts more than Nifty Microcap 250 and 4.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Paushak Limited has informed BSE and NSE that its Board of Directors will meet on 16 October 2026 to consider and approve unaudited financial results for the quarter and half year ended 30 September 2026 (Q2 and H1 FY27). The trading window for dealing in company securities by designated persons, which closed on 1 October 2026, will reopen 48 hours after the financial results are declared.
Routine board meeting intimation. No material impact expected until unaudited results are declared on or after 16 October 2026.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹89.32 Cr | ₹58.78 Cr | +52.0% |
| Operating profit | ₹16.57 Cr | ₹10.29 Cr | +61.0% |
| Profit after tax | ₹13.51 Cr | ₹8.61 Cr | +56.9% |
| EBITDA margin | 29.5% | 25.2% | +4.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.